AP
Aurinia Pharmaceuticals Inc
🇩🇪XSTU.IKAPGermanyHealthcare
€14.60EURdown -0.12 (-0.82%)ClosedEnd of day1:09 AM
Price€14.60-0.12 (-0.82%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- CA05156V1022
- CUSIP
- Not reported
Company
- Employees
- 128
- Headquarters
- Edmonton, United States
- CEO
- Mr. Kevin C. Tang
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- $2.35
- P/E LTM
- 7.26
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $311.51M+19.76%up year on year
- Net income
- $314.11M+418.03%up year on year
- Gross margin
- 90.36%+0.94%up year on year
- Free cash flow
- $173.58M+87.8%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.